chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Autopsy, Death, Fatigue, Splenitis, Viral infection
Clinical narrative: I celebrated my 21st birthday in November 2007. I did not live to see my 22nd. Suddenly, unexpectedly, and inexplicably, I died in bed in June. After an extensive autopsy, the cause of death is still a mystery. My family wants to know what happened to me. My family has concerns about the HPV vaccine, GARDASIL, which I had received only days before my death. They are researching the Vaccine Adverse Event Reporting System for accounts of such deaths. Can you help us find answers...above is one case report. This vaccine is a scam. It does not protect women. It causes infertility, spontaneous abortions, Guillain Barre syndrome. Cardiac impairment and or death, it cause HPV in some! The vaccine industry will be exposed because we the public will not be used and abused by vaccine industry any longer! The CDC and FDA should not be in charge of the VAERS data base when they are promoting their poison in the first place. VAERS is guilty of cover-ups and under reporting. Only 1-10% of victims are reported. That means there are hundreds of HPV vaccine victims not 27 as VAERS suggests! By withholding and suppressing informed consent from people the Pharma industry is violating Constitutional and Civil Rights of the victims. Enough of peddling poison to cull the population and make Pharma rich and further the CDC/other agencies Agenda.
Age: 20.0
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Autopsy, Death, Pulmonary oedema
Clinical narrative: I celebrated my 21st birthday in November 2007. I did not live to see my 22nd. Suddenly, unexpectedly, and inexplicably, I died in bed in June. After an extensive autopsy, the cause of death is still a mystery. My family wants to know what happened to me. My family has concerns about the HPV vaccine, GARDASIL, which I had received only days before my death. They are researching the Vaccine Adverse Event Reporting System for accounts of such deaths. Can you help us find answers...above is one case report. This vaccine is a scam. It does not protect women. It causes infertility, spontaneous abortions, Guillain Barre syndrome. Cardiac impairment and or death, it cause HPV in some! The vaccine industry will be exposed because we the public will not be used and abused by vaccine industry any longer! The CDC and FDA should not be in charge of the VAERS data base when they are promoting their poison in the first place. VAERS is guilty of cover-ups and under reporting. Only 1-10% of victims are reported. That means there are hundreds of HPV vaccine victims not 27 as VAERS suggests! By withholding and suppressing informed consent from people the Pharma industry is violating Constitutional and Civil Rights of the victims. Enough of peddling poison to cull the population and make Pharma rich and further the CDC/other agencies Agenda.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Asthenia, Blood test, Burning sensation, Computerised tomogram, Confusional state
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Decreased appetite, Disturbance in attention, Dizziness, Fatigue, Head injury
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Headache, Impaired driving ability, Impaired work ability, Middle ear effusion, Mononucleosis heterophile test
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Musculoskeletal stiffness, Myalgia, Neck pain, Nervous system disorder, Neurological examination abnormal
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Nuclear magnetic resonance imaging, Pain in extremity, Paraesthesia, Photosensitivity reaction, Pregnancy test
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Single functional kidney, Syncope, Thyroid function test, Vision blurred, Visual acuity tests normal
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Weight decreased
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Back injury, Bone pain, Burning sensation, Chest discomfort, Heart rate increased
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MEN
Symptoms: Migraine, Musculoskeletal discomfort, Myalgia, Paraesthesia, Syncope
Clinical narrative: Information has been received from a consumer concerning her daughter, a 17 year old female who on 04-SEP-2007 was vaccinated with the first dose of GARDASIL, 0.5ml. Concomitant therapy included meningococcal vaccine (manufacturer unspecified). Subsequently the patient fainted soon after and hurt her spine "a little over a year ago". Since then the patient has experienced extreme muscle pain, pressure in her chest, burning pain in her back, rapid heart beat, and extreme migraines. The patient is also experiencing tingling in her fingers. The patient had Blood work, MRI, and CT Scan. The patient' events did not improve. At the time of the report, the patient was not recovered. The patient sought medical attention. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site pain
Clinical narrative: This is in follow-up to report (s) previously submitted on 12/12/2008. Information has been received from a registered nurse concerning a 25 year old female with no relevant medical history reported who on 03-JUN-2008 and 05-AUG-2008, was vaccinated with the first and second dose of GARDASIL (lot number 0250X) 0.5ml IM into her left arm.  Concomitant therapy included allergy medicine as needed.  The patient experienced pain, soreness, decreased mobility, decreased strength in her left arm after administration of her second dose of GARDASIL.  The patient was examined by a neurologist on 11-NOV-2008.  He advised patient not to get the third dose.  Additional information has been requested. Follow up information received on 23-DEC-2008 from registered nurse. On 25-AUG-2008 patient reported to office that pain continued despite rest and NSAIDs and patient was referred to neurologist on 9-SEP-2008. On 13-NOV-2008 patient still had slight pain. The registered nurse also reported that the patient complained of soreness at the injection site. No further information is available.
Age: 25.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Asthenia, Injection site pain, Mobility decreased, Muscular weakness, Pain
Clinical narrative: This is in follow-up to report (s) previously submitted on 12/12/2008. Information has been received from a registered nurse concerning a 25 year old female with no relevant medical history reported who on 03-JUN-2008 and 05-AUG-2008, was vaccinated with the first and second dose of GARDASIL (lot number 0250X) 0.5ml IM into her left arm.  Concomitant therapy included allergy medicine as needed.  The patient experienced pain, soreness, decreased mobility, decreased strength in her left arm after administration of her second dose of GARDASIL.  The patient was examined by a neurologist on 11-NOV-2008.  He advised patient not to get the third dose.  Additional information has been requested. Follow up information received on 23-DEC-2008 from registered nurse. On 25-AUG-2008 patient reported to office that pain continued despite rest and NSAIDs and patient was referred to neurologist on 9-SEP-2008. On 13-NOV-2008 patient still had slight pain. The registered nurse also reported that the patient complained of soreness at the injection site. No further information is available.
Age: 19.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal pain upper, Drug exposure during pregnancy, Headache
Clinical narrative: Initial information has been received through the pregnancy registry for GARDASIL from a husband concerning his 19 year old wife who on 05-NOV-2008 was vaccinated with the first dose of GARDASIL. On 23-OCT-2008 the patient was vaccinated with hepatitis A (inactive) (manufacturer unknown), hepatitis B vaccine, recomb (manufacturer unknown), MMR II, DTaP (unspecified), poliovirus vaccine and influenza virus vaccine (unspecified). The husband called to report that his wife, the patient, was already learned that she was pregnant two to three weeks ago through a home urine pregnancy test. On 04-NOV-2008, "since two days ago" the patient experienced stomach ache, itching and difficulty breathing. It was reported that no laboratory diagnostic studies were performed. The patient's stomach ache and itching and difficulty breathing persisted. The LMP was reported as the end of Sep-2008. The patient sought medical attention through a nurse. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal pain upper, Blood human chorionic gonadotropin positive, Drug exposure during pregnancy, Dyspnoea, Pruritus
Clinical narrative: Initial information has been received through the pregnancy registry for GARDASIL from a husband concerning his 19 year old wife who on 05-NOV-2008 was vaccinated with the first dose of GARDASIL. On 23-OCT-2008 the patient was vaccinated with hepatitis A (inactive) (manufacturer unknown), hepatitis B vaccine, recomb (manufacturer unknown), MMR II, DTaP (unspecified), poliovirus vaccine and influenza virus vaccine (unspecified). The husband called to report that his wife, the patient, was already learned that she was pregnant two to three weeks ago through a home urine pregnancy test. On 04-NOV-2008, "since two days ago" the patient experienced stomach ache, itching and difficulty breathing. It was reported that no laboratory diagnostic studies were performed. The patient's stomach ache and itching and difficulty breathing persisted. The LMP was reported as the end of Sep-2008. The patient sought medical attention through a nurse. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: FLU3, HPV4, FLUN3, HPV4, UNK
Symptoms: Fall, Immediate post-injection reaction, Mouth injury, Syncope, Tooth injury
Clinical narrative: Information has been received from a physician and office manager concerning a 13 year old female who was vaccinated with GARDISAL (lot#659657/14870) (date, dose not reported). Concomitant therapy included flu vaccine and "PID" The patient experienced fainting twice after receiving an injection with GARDASIL and required oxygen after the second time. The patient passed out and fell off the table onto her two teeth; on 28-Oct-2008 the patient was taken to a Medical Center. The patient was not admitted but received sutures for her mouth. The patient needed dental work as follow-up and planned to see a dentist. The office manager was unsure of the patient's current status. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: FLU3, HPV4, FLUN3, HPV4, UNK
Symptoms: X-ray
Clinical narrative: Information has been received from a physician and office manager concerning a 13 year old female who was vaccinated with GARDISAL (lot#659657/14870) (date, dose not reported). Concomitant therapy included flu vaccine and "PID" The patient experienced fainting twice after receiving an injection with GARDASIL and required oxygen after the second time. The patient passed out and fell off the table onto her two teeth; on 28-Oct-2008 the patient was taken to a Medical Center. The patient was not admitted but received sutures for her mouth. The patient needed dental work as follow-up and planned to see a dentist. The office manager was unsure of the patient's current status. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: FLU3, HPV4, FLUN3, HPV4, UNK
Symptoms: Fall, Loss of consciousness, Oxygen supplementation, Suture insertion, Syncope
Clinical narrative: Information has been received from a physician and office manager concerning a 13 year old female who was vaccinated with GARDISAL (lot#659657/14870) (date, dose not reported). Concomitant therapy included flu vaccine and "PID" The patient experienced fainting twice after receiving an injection with GARDASIL and required oxygen after the second time. The patient passed out and fell off the table onto her two teeth; on 28-Oct-2008 the patient was taken to a Medical Center. The patient was not admitted but received sutures for her mouth. The patient needed dental work as follow-up and planned to see a dentist. The office manager was unsure of the patient's current status. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: FLU3, HPV4, FLUN3, HPV4, UNK
Symptoms: Tooth injury
Clinical narrative: Information has been received from a physician and office manager concerning a 13 year old female who was vaccinated with GARDISAL (lot#659657/14870) (date, dose not reported). Concomitant therapy included flu vaccine and "PID" The patient experienced fainting twice after receiving an injection with GARDASIL and required oxygen after the second time. The patient passed out and fell off the table onto her two teeth; on 28-Oct-2008 the patient was taken to a Medical Center. The patient was not admitted but received sutures for her mouth. The patient needed dental work as follow-up and planned to see a dentist. The office manager was unsure of the patient's current status. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Discomfort, Injection site atrophy, Injection site discolouration, Injection site swelling, Muscular weakness
Clinical narrative: Information has been received from an office manager at a physician's office concerning a 13 year old female who on 31-Aug-2006 and 09-Nov-2006, received the first and second doses of GARDASIL (lot# not provided). On 29-Sep-2008 the patient received the third dose of GARDASIL, IM into the left deltoid (lot# 66104/0548X). Concomitant therapy included YASMIN. A couple of days (also reported as "several days" in follow up) post the third dose of vaccination, the patient experienced "pain and dot above the injection site that eventually widened and spread". It was reported that the patient's injection site reaction was presently two inches in diameter and had a concave look (or divet) whereby the muscle seemed to have deteriorated. In follow-up, it was reported the 2 inch by 2 inch area was concave where the muscle seemed to have deteriorated. The patient reported adverse events on 11-NOV-2008. The patient was seeing an orthopedist. A lab work of CPK was performed (result unknown). At the time of the report, on 12-NOV-2008, the outcome of the patient was unknown. Additional information is not expected. This is in follow-up to report(s) previously submitted on 12/12/2008. In follow up the patient's physician reported that the dot that the patient had above the injection site after receiving GARDASIL had gotten a lot worse and had become bigger. The physician mentioned that the patient had a "huge concave" area on the arm. The patient had experienced muscle weakness and atrophy in the area and had seen by an orthopedic and was currently undergoing physical therapy. Follow-up information received from the physician indicated that the patient had atrophy of the muscle as well as depigmentation. However, serum aldolase test and serum creatine kinase test (CPK, muscle enzymes) were normal. The patient was referred to an orthopedist and then to a neurologist because she developed a tremor. The patient also developed an indentation at the injection site. The indentation started out small when first reported by the patient. After follow-up, the area was now (12-JAN-2009) much larger. She now (12-JAN-2009) had discoloration in the area also. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Blood aldosterone normal, Blood creatine phosphokinase normal, Injection site atrophy, Injection site induration, Injection site pain
Clinical narrative: Information has been received from an office manager at a physician's office concerning a 13 year old female who on 31-Aug-2006 and 09-Nov-2006, received the first and second doses of GARDASIL (lot# not provided). On 29-Sep-2008 the patient received the third dose of GARDASIL, IM into the left deltoid (lot# 66104/0548X). Concomitant therapy included YASMIN. A couple of days (also reported as "several days" in follow up) post the third dose of vaccination, the patient experienced "pain and dot above the injection site that eventually widened and spread". It was reported that the patient's injection site reaction was presently two inches in diameter and had a concave look (or divet) whereby the muscle seemed to have deteriorated. In follow-up, it was reported the 2 inch by 2 inch area was concave where the muscle seemed to have deteriorated. The patient reported adverse events on 11-NOV-2008. The patient was seeing an orthopedist. A lab work of CPK was performed (result unknown). At the time of the report, on 12-NOV-2008, the outcome of the patient was unknown. Additional information is not expected. This is in follow-up to report(s) previously submitted on 12/12/2008. In follow up the patient's physician reported that the dot that the patient had above the injection site after receiving GARDASIL had gotten a lot worse and had become bigger. The physician mentioned that the patient had a "huge concave" area on the arm. The patient had experienced muscle weakness and atrophy in the area and had seen by an orthopedic and was currently undergoing physical therapy. Follow-up information received from the physician indicated that the patient had atrophy of the muscle as well as depigmentation. However, serum aldolase test and serum creatine kinase test (CPK, muscle enzymes) were normal. The patient was referred to an orthopedist and then to a neurologist because she developed a tremor. The patient also developed an indentation at the injection site. The indentation started out small when first reported by the patient. After follow-up, the area was now (12-JAN-2009) much larger. She now (12-JAN-2009) had discoloration in the area also. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Muscular weakness, Skin depigmentation, Skin discolouration, Tremor
Clinical narrative: Information has been received from an office manager at a physician's office concerning a 13 year old female who on 31-Aug-2006 and 09-Nov-2006, received the first and second doses of GARDASIL (lot# not provided). On 29-Sep-2008 the patient received the third dose of GARDASIL, IM into the left deltoid (lot# 66104/0548X). Concomitant therapy included YASMIN. A couple of days (also reported as "several days" in follow up) post the third dose of vaccination, the patient experienced "pain and dot above the injection site that eventually widened and spread". It was reported that the patient's injection site reaction was presently two inches in diameter and had a concave look (or divet) whereby the muscle seemed to have deteriorated. In follow-up, it was reported the 2 inch by 2 inch area was concave where the muscle seemed to have deteriorated. The patient reported adverse events on 11-NOV-2008. The patient was seeing an orthopedist. A lab work of CPK was performed (result unknown). At the time of the report, on 12-NOV-2008, the outcome of the patient was unknown. Additional information is not expected. This is in follow-up to report(s) previously submitted on 12/12/2008. In follow up the patient's physician reported that the dot that the patient had above the injection site after receiving GARDASIL had gotten a lot worse and had become bigger. The physician mentioned that the patient had a "huge concave" area on the arm. The patient had experienced muscle weakness and atrophy in the area and had seen by an orthopedic and was currently undergoing physical therapy. Follow-up information received from the physician indicated that the patient had atrophy of the muscle as well as depigmentation. However, serum aldolase test and serum creatine kinase test (CPK, muscle enzymes) were normal. The patient was referred to an orthopedist and then to a neurologist because she developed a tremor. The patient also developed an indentation at the injection site. The indentation started out small when first reported by the patient. After follow-up, the area was now (12-JAN-2009) much larger. She now (12-JAN-2009) had discoloration in the area also. Additional information has been requested.
Age: 25.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Abdominal tenderness, Chills, Dizziness, Headache, Hypoaesthesia
Clinical narrative: After recieving 3 doses of the anthrax vaccine, lot # FAV 030, the numbness of injection arm and fingertip tingling, headaches and dizziness for many hours after each shot. On 9 June 1999, I recieved shot #4 from Lot FAV 041.  Again the numbness of arm, tingling and headache that lasted for several days. 25 June 1999, While on flight duty, a trip ended w/ a trip to the base hospital ER. Being transported to the ER for Extreme headache, extreme vomiting, dizziness, blurred vision abdominal tenderness, chills that persisted for 6-8 hours prior.  Symptoms began 24 June 1999 and tried Tylenol for relief but no relief found.  When released from hospital mid morning on 25 June 1999 after Toradol injection, headache persisted for multiple days and controlled pain w/ Motrin. Since AVIP series, headaches have become almost daily, Joint pain, Hypertension, fatigue, and out of the blue vomiting w/ no other side effects every couple of months. My doctor has prescribed Blood pressure meds, and Ibuprofen for joint pain and headaches. Low back pain has been diagnosed as degenerative disc disease. Getting out of bed every morning is very painful. I am 34 years old and feel like I am 70 years old.
Age: 25.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Vision blurred, Vomiting
Clinical narrative: After recieving 3 doses of the anthrax vaccine, lot # FAV 030, the numbness of injection arm and fingertip tingling, headaches and dizziness for many hours after each shot. On 9 June 1999, I recieved shot #4 from Lot FAV 041.  Again the numbness of arm, tingling and headache that lasted for several days. 25 June 1999, While on flight duty, a trip ended w/ a trip to the base hospital ER. Being transported to the ER for Extreme headache, extreme vomiting, dizziness, blurred vision abdominal tenderness, chills that persisted for 6-8 hours prior.  Symptoms began 24 June 1999 and tried Tylenol for relief but no relief found.  When released from hospital mid morning on 25 June 1999 after Toradol injection, headache persisted for multiple days and controlled pain w/ Motrin. Since AVIP series, headaches have become almost daily, Joint pain, Hypertension, fatigue, and out of the blue vomiting w/ no other side effects every couple of months. My doctor has prescribed Blood pressure meds, and Ibuprofen for joint pain and headaches. Low back pain has been diagnosed as degenerative disc disease. Getting out of bed every morning is very painful. I am 34 years old and feel like I am 70 years old.
Age: 25.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Abdominal tenderness, Arthralgia, Back pain, Chills, Dizziness
Clinical narrative: After recieving 3 doses of the anthrax vaccine, lot # FAV 030, the numbness of injection arm and fingertip tingling, headaches and dizziness for many hours after each shot. On 9 June 1999, I recieved shot #4 from Lot FAV 041.  Again the numbness of arm, tingling and headache that lasted for several days. 25 June 1999, While on flight duty, a trip ended w/ a trip to the base hospital ER. Being transported to the ER for Extreme headache, extreme vomiting, dizziness, blurred vision abdominal tenderness, chills that persisted for 6-8 hours prior.  Symptoms began 24 June 1999 and tried Tylenol for relief but no relief found.  When released from hospital mid morning on 25 June 1999 after Toradol injection, headache persisted for multiple days and controlled pain w/ Motrin. Since AVIP series, headaches have become almost daily, Joint pain, Hypertension, fatigue, and out of the blue vomiting w/ no other side effects every couple of months. My doctor has prescribed Blood pressure meds, and Ibuprofen for joint pain and headaches. Low back pain has been diagnosed as degenerative disc disease. Getting out of bed every morning is very painful. I am 34 years old and feel like I am 70 years old.
Age: 25.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Fatigue, Headache, Hypertension, Hypoaesthesia, Intervertebral disc degeneration
Clinical narrative: After recieving 3 doses of the anthrax vaccine, lot # FAV 030, the numbness of injection arm and fingertip tingling, headaches and dizziness for many hours after each shot. On 9 June 1999, I recieved shot #4 from Lot FAV 041.  Again the numbness of arm, tingling and headache that lasted for several days. 25 June 1999, While on flight duty, a trip ended w/ a trip to the base hospital ER. Being transported to the ER for Extreme headache, extreme vomiting, dizziness, blurred vision abdominal tenderness, chills that persisted for 6-8 hours prior.  Symptoms began 24 June 1999 and tried Tylenol for relief but no relief found.  When released from hospital mid morning on 25 June 1999 after Toradol injection, headache persisted for multiple days and controlled pain w/ Motrin. Since AVIP series, headaches have become almost daily, Joint pain, Hypertension, fatigue, and out of the blue vomiting w/ no other side effects every couple of months. My doctor has prescribed Blood pressure meds, and Ibuprofen for joint pain and headaches. Low back pain has been diagnosed as degenerative disc disease. Getting out of bed every morning is very painful. I am 34 years old and feel like I am 70 years old.
Age: 25.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Paraesthesia, Vaccine positive rechallenge, Vision blurred, Vomiting
Clinical narrative: After recieving 3 doses of the anthrax vaccine, lot # FAV 030, the numbness of injection arm and fingertip tingling, headaches and dizziness for many hours after each shot. On 9 June 1999, I recieved shot #4 from Lot FAV 041.  Again the numbness of arm, tingling and headache that lasted for several days. 25 June 1999, While on flight duty, a trip ended w/ a trip to the base hospital ER. Being transported to the ER for Extreme headache, extreme vomiting, dizziness, blurred vision abdominal tenderness, chills that persisted for 6-8 hours prior.  Symptoms began 24 June 1999 and tried Tylenol for relief but no relief found.  When released from hospital mid morning on 25 June 1999 after Toradol injection, headache persisted for multiple days and controlled pain w/ Motrin. Since AVIP series, headaches have become almost daily, Joint pain, Hypertension, fatigue, and out of the blue vomiting w/ no other side effects every couple of months. My doctor has prescribed Blood pressure meds, and Ibuprofen for joint pain and headaches. Low back pain has been diagnosed as degenerative disc disease. Getting out of bed every morning is very painful. I am 34 years old and feel like I am 70 years old.
Age: 0.17
Sex: M
Vaccine: RV5, RV5
Symptoms: Rash
Clinical narrative: Information has been received from a medical assistant concerning a 2 month old male with no pertinent medical history and no known drug allergies who on 17-NOV-2008 was vaccinated P.O. with a first dose of ROTATEQ (lot # 660289/1888U).  The patient developed a fine rash over his torso immediately after vaccination.  The patient sought medical attention at physician's office and was treated BENADRYL.  Subsequently, the patient recovered from fine rash over torso on an unspecified date.  Additional information has been requested. This is in follow-up to reports previously submitted on 12/12/2008. Information has been received from a medical assistant (C.M.A.) concerning a 2 month old male with no pertinent medical history and no known drug allergies who on 17-NOV-2008 was vaccinated P.O. with a first dose of ROTATEQ (lot # 660289/1888U).  The patient developed a fine rash over his torso immediately after vaccination.  The patient sought medical attention at physician's office and was treated BENADRYL.  Subsequently, the patient recovered from fine rash over torso on an unspecified date. Additional information is not expected.
Age: 37.0
Sex: F
Vaccine: TD, TD
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Patient received d/t booster in ER on 11-15-08. She subsequently developed a rash (73"), red and hot site. Also reported to VAERS.
Age: 37.0
Sex: F
Vaccine: TD, TD
Symptoms: Injection site erythema, Injection site warmth, Rash
Clinical narrative: Patient received d/t booster in ER on 11-15-08. She subsequently developed a rash (73"), red and hot site. Also reported to VAERS.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Anxiety, Blood test normal, CSF test normal, Dysaesthesia, Muscular weakness
Clinical narrative: Initial report received from a patient who is a critical care nurse on 02 December 2008. A 45-year-old female patient received an intramuscular left deltoid injection of FLUZONE SV 2008-2009 (lot number U2804AA) on 16 October 2008 and seven days later, on 23 October 2008, she first noticed a stiff neck when doing pilates. She later noticed a tingling sensation on both trigeminal nerves, greater on the left than on the right. The patient also had a feeling of impending doom. The patient attributed the stiff neck to a previous muscle injury (not specified). It was also indicated that the patient had acupuncture on an unspecified date. Later in the evening of 23 October 2008, the patient experienced an electrical shooting sensation in all four extremities and went to the emergency room for evaluation. An MRI of the head and neck and a test on blood vessels (not specified) were normal. The patient was sent home with instructions to follow-up with a neurologist. By 27 October 2008, the symptoms had worsened. The patient complained of numbness and tingling in all extremities, which progressed to complete loss of sensation in both lower and upper extremities. Additionally, the patient had significant upper extremity weakness. The patient was admitted to the hospital and tests were completed to rule out GBS (Guillain-Barre Syndrome) and MS (Multiple Sclerosis). The final diagnosis was central "demyelinization". The patient received treatment with SOLUMEDROL while in ICU (intensive care unit) with significant improvement. The patient was discharged from the hospital on 31 October 2008. At the time of the report, the patient had intermittent abnormal sensory feelings and intermittent upper extremity weakness. The patient continued to follow-up with her neurologist. Contact information for the neurologist was provided. Documents held by sender: None.  Follow-up: Intermittent dysesthesias of head/face, trunk/back, all 4 extremities. UE/shoulder girdle muscle weakness (initial strength good, endurance strong remains with affect). At 14 months post-event without complete resolution this degree of residual deficit may be permanent.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Musculoskeletal stiffness, Nuclear magnetic resonance imaging normal, Paraesthesia, Sensory loss, Trigeminal nerve disorder
Clinical narrative: Initial report received from a patient who is a critical care nurse on 02 December 2008. A 45-year-old female patient received an intramuscular left deltoid injection of FLUZONE SV 2008-2009 (lot number U2804AA) on 16 October 2008 and seven days later, on 23 October 2008, she first noticed a stiff neck when doing pilates. She later noticed a tingling sensation on both trigeminal nerves, greater on the left than on the right. The patient also had a feeling of impending doom. The patient attributed the stiff neck to a previous muscle injury (not specified). It was also indicated that the patient had acupuncture on an unspecified date. Later in the evening of 23 October 2008, the patient experienced an electrical shooting sensation in all four extremities and went to the emergency room for evaluation. An MRI of the head and neck and a test on blood vessels (not specified) were normal. The patient was sent home with instructions to follow-up with a neurologist. By 27 October 2008, the symptoms had worsened. The patient complained of numbness and tingling in all extremities, which progressed to complete loss of sensation in both lower and upper extremities. Additionally, the patient had significant upper extremity weakness. The patient was admitted to the hospital and tests were completed to rule out GBS (Guillain-Barre Syndrome) and MS (Multiple Sclerosis). The final diagnosis was central "demyelinization". The patient received treatment with SOLUMEDROL while in ICU (intensive care unit) with significant improvement. The patient was discharged from the hospital on 31 October 2008. At the time of the report, the patient had intermittent abnormal sensory feelings and intermittent upper extremity weakness. The patient continued to follow-up with her neurologist. Contact information for the neurologist was provided. Documents held by sender: None.  Follow-up: Intermittent dysesthesias of head/face, trunk/back, all 4 extremities. UE/shoulder girdle muscle weakness (initial strength good, endurance strong remains with affect). At 14 months post-event without complete resolution this degree of residual deficit may be permanent.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Demyelination, Hypoaesthesia, Intensive care, Laboratory test normal, Muscular weakness
Clinical narrative: Initial report received from a patient who is a critical care nurse on 02 December 2008. A 45-year-old female patient received an intramuscular left deltoid injection of FLUZONE SV 2008-2009 (lot number U2804AA) on 16 October 2008 and seven days later, on 23 October 2008, she first noticed a stiff neck when doing pilates. She later noticed a tingling sensation on both trigeminal nerves, greater on the left than on the right. The patient also had a feeling of impending doom. The patient attributed the stiff neck to a previous muscle injury (not specified). It was also indicated that the patient had acupuncture on an unspecified date. Later in the evening of 23 October 2008, the patient experienced an electrical shooting sensation in all four extremities and went to the emergency room for evaluation. An MRI of the head and neck and a test on blood vessels (not specified) were normal. The patient was sent home with instructions to follow-up with a neurologist. By 27 October 2008, the symptoms had worsened. The patient complained of numbness and tingling in all extremities, which progressed to complete loss of sensation in both lower and upper extremities. Additionally, the patient had significant upper extremity weakness. The patient was admitted to the hospital and tests were completed to rule out GBS (Guillain-Barre Syndrome) and MS (Multiple Sclerosis). The final diagnosis was central "demyelinization". The patient received treatment with SOLUMEDROL while in ICU (intensive care unit) with significant improvement. The patient was discharged from the hospital on 31 October 2008. At the time of the report, the patient had intermittent abnormal sensory feelings and intermittent upper extremity weakness. The patient continued to follow-up with her neurologist. Contact information for the neurologist was provided. Documents held by sender: None.  Follow-up: Intermittent dysesthesias of head/face, trunk/back, all 4 extremities. UE/shoulder girdle muscle weakness (initial strength good, endurance strong remains with affect). At 14 months post-event without complete resolution this degree of residual deficit may be permanent.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Musculoskeletal stiffness, Nuclear magnetic resonance imaging normal, Paraesthesia, Sensory loss
Clinical narrative: Initial report received from a patient who is a critical care nurse on 02 December 2008. A 45-year-old female patient received an intramuscular left deltoid injection of FLUZONE SV 2008-2009 (lot number U2804AA) on 16 October 2008 and seven days later, on 23 October 2008, she first noticed a stiff neck when doing pilates. She later noticed a tingling sensation on both trigeminal nerves, greater on the left than on the right. The patient also had a feeling of impending doom. The patient attributed the stiff neck to a previous muscle injury (not specified). It was also indicated that the patient had acupuncture on an unspecified date. Later in the evening of 23 October 2008, the patient experienced an electrical shooting sensation in all four extremities and went to the emergency room for evaluation. An MRI of the head and neck and a test on blood vessels (not specified) were normal. The patient was sent home with instructions to follow-up with a neurologist. By 27 October 2008, the symptoms had worsened. The patient complained of numbness and tingling in all extremities, which progressed to complete loss of sensation in both lower and upper extremities. Additionally, the patient had significant upper extremity weakness. The patient was admitted to the hospital and tests were completed to rule out GBS (Guillain-Barre Syndrome) and MS (Multiple Sclerosis). The final diagnosis was central "demyelinization". The patient received treatment with SOLUMEDROL while in ICU (intensive care unit) with significant improvement. The patient was discharged from the hospital on 31 October 2008. At the time of the report, the patient had intermittent abnormal sensory feelings and intermittent upper extremity weakness. The patient continued to follow-up with her neurologist. Contact information for the neurologist was provided. Documents held by sender: None.  Follow-up: Intermittent dysesthesias of head/face, trunk/back, all 4 extremities. UE/shoulder girdle muscle weakness (initial strength good, endurance strong remains with affect). At 14 months post-event without complete resolution this degree of residual deficit may be permanent.
Age: 13.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Biopsy skin, Injection site reaction, Skin reaction
Clinical narrative: Information has been received amoxicillin who was vaccinated with 3 doses of GARDASIL vaccine (route and site not reported).  The patient had no reaction to the first 2 doses.  Right after the 3rd dose of GARDASIL vaccine the patient experienced a reaction at the injection site, that later spread to most of her body.  The patient lost tremendous amount of pigmentation in her skin, and the skin is dry and itchy and a lot of times cracks from the dryness.  The pediatrician referred her to a dermatologist where she had biopsy done.  The office said it was not an allergic reaction.   The loss of pigmentation and dryness was mostly all over her face, both arms and legs.  The patient's experiences persisted.  Follow-up information was received from a physician. The physician indicated that the patient developed an eczematous/psoriatic reaction to vaccine. The patient did no recovered. This is one of several reports received from the same source.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 12/17/2008. Follow-up information was received from a certified medical assistant who indicated that the patient on 01-APR-2008 was vaccinated with the third dose of GARDASIL vaccine (LOT# 659182/1757U) and the onset date of adverse events was 02-APR-2008. Ths skin reaction surround site of injectition within weeks of vaccine. Then generalized over entire skin surface over the next 3-4 months. No further information is available
Age: 13.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Biopsy skin, Dry skin, Eczema, Injection site reaction, Pigmentation disorder
Clinical narrative: Information has been received amoxicillin who was vaccinated with 3 doses of GARDASIL vaccine (route and site not reported).  The patient had no reaction to the first 2 doses.  Right after the 3rd dose of GARDASIL vaccine the patient experienced a reaction at the injection site, that later spread to most of her body.  The patient lost tremendous amount of pigmentation in her skin, and the skin is dry and itchy and a lot of times cracks from the dryness.  The pediatrician referred her to a dermatologist where she had biopsy done.  The office said it was not an allergic reaction.   The loss of pigmentation and dryness was mostly all over her face, both arms and legs.  The patient's experiences persisted.  Follow-up information was received from a physician. The physician indicated that the patient developed an eczematous/psoriatic reaction to vaccine. The patient did no recovered. This is one of several reports received from the same source.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 12/17/2008. Follow-up information was received from a certified medical assistant who indicated that the patient on 01-APR-2008 was vaccinated with the third dose of GARDASIL vaccine (LOT# 659182/1757U) and the onset date of adverse events was 02-APR-2008. Ths skin reaction surround site of injectition within weeks of vaccine. Then generalized over entire skin surface over the next 3-4 months. No further information is available
Age: 13.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Pruritus, Psoriasis
Clinical narrative: Information has been received amoxicillin who was vaccinated with 3 doses of GARDASIL vaccine (route and site not reported).  The patient had no reaction to the first 2 doses.  Right after the 3rd dose of GARDASIL vaccine the patient experienced a reaction at the injection site, that later spread to most of her body.  The patient lost tremendous amount of pigmentation in her skin, and the skin is dry and itchy and a lot of times cracks from the dryness.  The pediatrician referred her to a dermatologist where she had biopsy done.  The office said it was not an allergic reaction.   The loss of pigmentation and dryness was mostly all over her face, both arms and legs.  The patient's experiences persisted.  Follow-up information was received from a physician. The physician indicated that the patient developed an eczematous/psoriatic reaction to vaccine. The patient did no recovered. This is one of several reports received from the same source.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 12/17/2008. Follow-up information was received from a certified medical assistant who indicated that the patient on 01-APR-2008 was vaccinated with the third dose of GARDASIL vaccine (LOT# 659182/1757U) and the onset date of adverse events was 02-APR-2008. Ths skin reaction surround site of injectition within weeks of vaccine. Then generalized over entire skin surface over the next 3-4 months. No further information is available